Screening for hepatocellular carcinoma: Is it cost-effective?

Liver Transplantation

Volumn 9, Issue 7, 2003, Pages 682-683

  Wolf, David C ^a  

^a WESTCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; ALCOHOL; ALPHA FETOPROTEIN; HEPATITIS B SURFACE ANTIGEN;

ARTIFICIAL EMBOLISM; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER SCREENING; CANCER SURVIVAL; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DIAGNOSTIC IMAGING; ECHOGRAPHY; EDITORIAL; EUROPE; HEPATITIS C; HOSPITAL ADMISSION; HUMAN; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LIVING DONOR; PARTIAL HEPATECTOMY; PATIENT REFERRAL; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PROBABILITY; QUALITY ADJUSTED LIFE YEAR; STATISTICAL MODEL; TIME; UNITED STATES;

EID: 0037810639     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1053/jlts.2003.50139     Document Type: Article

References (10)

1. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999;340:745-750.
2. Cołombo M, DeFranchis R, Del Ninno E, Sangiovanni A, DeFazio C, Tommasini M, et al. Hepatocellular carcinoma in Italian patients w ith cirrhosis. N Engl J Med 1991;325:675-680.
3. Pateron D, Ganne N, Trinchet JC, Aurousseau MH, Mal F, Meicler C, et al. Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis. J Hepatol 1994; 20-65-71.
4. Bolondi L, Sofia S, Siringo S, Gaiani S, Casali A, Zironi G, et al. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: A cost effectiveness analysis. Gut 2001;48:251-259.
5. Trevisani F, De Notariis S, Rapaccini G, Farinati F, Benvegnu L, Zoli M, et al. Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: Effects on cancer stage and patient survival (Italian experience). Am J Gastroenterol 2002; 97:734-744.
6. McMahon BJ, Bulkow L, Harpster A, Snowball M, Lanier A, Sacco F, et al. Screening for hepatocellular carcinoma in Alaska natives infected with chronic hepatitis B: A 16-year population-based study. Hepatology 2000;32:842-846.
7. Arguedas MR, Chen VK, Eloubeidi MA, Fallon MB. Screening for hepatocellular carinoma in patients with hepatitis C cirrhosis: A cost-utility analysis. Am J Gastroenterol 2003;98:679-690.
8. Everson GT. Increasing incidence and pretransplantation screening of hepatocellular carcinoma. Liver Transpl 2000; 6(suppl):S2-S10.
9. Sarasin FP, Giostra E, Hadengue A. Cost-effectiveness of screening for detection of small hepatocellular carcinoma in Western patients with Child-Pugh class A cirrhosis. Am J Med 1996;101: 422-434.
10. Saab S, Ly D, Nieto J, Kanwal F, Lu D, Raman S, et al. Hepatocellular carcinoma screening in patients waiting for liver transplantation: A decision analytic model. Liver Transpl 2003;9: 672-681.